GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Cyclically Adjusted Revenue per Share

Denis Chem Lab (BOM:537536) Cyclically Adjusted Revenue per Share : ₹127.78 (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Denis Chem Lab's adjusted revenue per share for the three months ended in Mar. 2025 was ₹29.826. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹127.78 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Denis Chem Lab's average Cyclically Adjusted Revenue Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-06-30), Denis Chem Lab's current stock price is ₹101.95. Denis Chem Lab's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₹127.78. Denis Chem Lab's Cyclically Adjusted PS Ratio of today is 0.80.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Denis Chem Lab was 1.66. The lowest was 0.40. And the median was 0.87.


Denis Chem Lab Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Denis Chem Lab's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab Cyclically Adjusted Revenue per Share Chart

Denis Chem Lab Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 159.62 124.80 127.78

Denis Chem Lab Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.80 126.88 128.92 128.95 127.78

Competitive Comparison of Denis Chem Lab's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denis Chem Lab's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's Cyclically Adjusted PS Ratio falls into.


;
;

Denis Chem Lab Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Denis Chem Lab's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=29.826/157.5517*157.5517
=29.826

Current CPI (Mar. 2025) = 157.5517.

Denis Chem Lab Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 24.202 99.841 38.192
201509 28.073 101.753 43.467
201512 25.708 102.901 39.362
201603 26.539 102.518 40.786
201606 30.589 105.961 45.482
201609 27.352 105.961 40.669
201612 25.030 105.196 37.487
201703 22.350 105.196 33.474
201706 20.968 107.109 30.843
201709 25.026 109.021 36.166
201712 20.428 109.404 29.418
201803 21.162 109.786 30.369
201806 23.116 111.317 32.717
201809 23.406 115.142 32.027
201812 22.943 115.142 31.394
201903 19.852 118.202 26.461
201906 25.138 120.880 32.764
201909 24.190 123.175 30.941
201912 26.078 126.235 32.547
202003 22.552 124.705 28.492
202006 16.761 127.000 20.793
202009 19.551 130.118 23.673
202012 22.058 130.889 26.551
202103 19.836 131.771 23.717
202106 23.859 134.084 28.035
202109 22.944 135.847 26.610
202112 24.498 138.161 27.936
202203 27.261 138.822 30.939
202206 28.376 142.347 31.407
202209 32.044 144.661 34.899
202212 26.961 145.763 29.142
202303 28.470 146.865 30.542
202306 30.583 150.280 32.063
202309 32.673 151.492 33.980
202312 28.907 152.924 29.782
202403 28.766 153.035 29.615
202406 29.806 155.789 30.143
202409 34.401 157.882 34.329
202412 30.890 158.323 30.740
202503 29.826 157.552 29.826

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Denis Chem Lab  (BOM:537536) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Denis Chem Lab's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=101.95/127.78
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Denis Chem Lab was 1.66. The lowest was 0.40. And the median was 0.87.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Denis Chem Lab Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab Business Description

Industry
Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab Headlines

No Headlines